angiotensin ii, des-phe(8)- has been researched along with okadaic acid in 1 studies
| Studies (angiotensin ii, des-phe(8)-) | Trials (angiotensin ii, des-phe(8)-) | Recent Studies (post-2010) (angiotensin ii, des-phe(8)-) | Studies (okadaic acid) | Trials (okadaic acid) | Recent Studies (post-2010) (okadaic acid) |
|---|---|---|---|---|---|
| 1,533 | 21 | 995 | 3,865 | 2 | 658 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ferrario, CM; Gallagher, PE; Tallant, EA | 1 |
1 other study(ies) available for angiotensin ii, des-phe(8)- and okadaic acid
| Article | Year |
|---|---|
MAP kinase/phosphatase pathway mediates the regulation of ACE2 by angiotensin peptides.
Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Cells, Cultured; Flavonoids; MAP Kinase Signaling System; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinase Phosphatases; Mitogen-Activated Protein Kinases; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Okadaic Acid; Peptide Fragments; Peptidyl-Dipeptidase A; Protein Kinase Inhibitors; Proto-Oncogene Mas; Proto-Oncogene Proteins; Rats; Rats, Sprague-Dawley; Receptors, G-Protein-Coupled; RNA, Messenger; Vanadates | 2008 |